Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.

The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant option.

"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...